EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MELHAC Improves Glucose and Lipid Metabolism in HFD + Alloxan-Induced Mice

Zihao Wang, Yang Yang, Zhixi Geng, Senyang Hu, Wenhua Jin, Hejing Tang, Jianmin Zou, Chang Liu, Yinhua Zhu iD

Nutrients · 02.07.2026 · 18 (13) · 2145

DOI: 10.3390/nu18132145 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 02.07.2026. Verfasst von Zihao Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Advanced Innovation Center for Food Nutrition and Human Health, Department of Nutrition and Health, China Agricultural University, Beijing 10…. Hauptthemen laut MEDLINE: Lipid Metabolism, Diet, High-Fat, Blood Glucose, Plant Extracts. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Green Food Development Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glucose and lipid metabolism disorders are characterized by hyperglycemia, dyslipidemia, hepatic oxidative stress, lipid accumulation, and gut microbiota dysbiosis, all of which contribute to progressive metabolic dysfunction and tissue injury. As a plant extract mixture derived from mulberry leaves, lotus leaves, and Eucommia leaves, MELHAC (Mulberry–Eucommia–Lotus Herbal Aqueous Complex) was developed as a medicinal and edible formula with potential multi-component metabolic regulatory activity. In the present study, we systematically evaluated the effects of MELHAC on glucose and lipid metabolic abnormalities in high-fat diet (HFD) plus alloxan-induced mice.

Methods

The phytochemical profile of MELHAC was characterized using untargeted LC–MS and network pharmacology. Its metabolic effects were evaluated in HFD plus alloxan-induced mice by measuring fasting blood glucose, serum lipid parameters, glucose tolerance, hepatic oxidative stress markers, histopathological changes, hepatic lipid accumulation, gut microbiota composition, and preliminary safety indices.

Results

Chemical characterization revealed that MELHAC contains abundant bioactive constituents dominated by flavonoids, phenolic acids and alkaloids. In vivo experiments demonstrated that MELHAC lowered fasting blood glucose, total cholesterol and triglyceride levels, while ameliorating glucose intolerance and pathological damage in the liver, kidney and pancreas. MELHAC also improved liver-related biochemical abnormalities, increased hepatic superoxide dismutase, decreased malondialdehyde, and reduced hepatic lipid accumulation, indicating protective effects against oxidative stress and steatosis associated with metabolic dysfunction. In addition, MELHAC modulated gut microbial community structure and differential taxa linked to metabolic homeostasis. Short-term high-dose administration did not cause obvious abnormalities in serum biochemical, hematological, or histopathological indices.

Conclusions

These findings suggest that MELHAC has potential as a plant-derived functional ingredient for improving glucose and lipid metabolic disorders and may provide an experimental basis for the future development of functional foods targeting metabolic health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipid MetabolismDiet, High-FatBlood GlucosePlant ExtractsAnimalsMaleMiceLiverOxidative StressAlloxanGastrointestinal MicrobiomeMice, Inbred C57BL

Stichwörter der Autor:innen

glucose and lipid metabolismgut microbiotahepatic oxidative stresshigh-fat diet plus alloxanmetabolomicsplant extract mixturesafety evaluation

Substanzen

Blood GlucosePlant ExtractsAlloxan

Autor:innen und Institutionen

  • Beijing Advanced Innovation Center for Food Nutrition and Human Health, Department of Nutrition and Health, China Agricultural University, Beijing 100193, China.
  • Institute of Environment and Sustainable Development in Agriculture, Chinese Academy of Agricuitural Sciences, Key Laboratory of Agricultural Environment, MARA, Beijing 100081, China.

ORCID-Profile: Yinhua Zhu

Förderung

  • China Green Food Development Center

Zitieren

APA

Wang, Z., Yang, Y., Geng, Z., Hu, S., Jin, W., Tang, H., Zou, J., Liu, C., & Zhu, Y. (2026). MELHAC Improves Glucose and Lipid Metabolism in HFD + Alloxan-Induced Mice. Nutrients, 18(13), 2145. https://doi.org/10.3390/nu18132145

Vancouver

Wang Z, Yang Y, Geng Z, Hu S, Jin W, Tang H, et al. MELHAC Improves Glucose and Lipid Metabolism in HFD + Alloxan-Induced Mice. Nutrients. 2026;18(13):2145. doi:10.3390/nu18132145

BibTeX
@article{Wang2026,
  author = {Wang, Zihao and Yang, Yang and Geng, Zhixi and Hu, Senyang and Jin, Wenhua and Tang, Hejing and Zou, Jianmin and Liu, Chang and Zhu, Yinhua},
  title = {MELHAC Improves Glucose and Lipid Metabolism in HFD + Alloxan-Induced Mice},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {13},
  pages = {2145},
  doi = {10.3390/nu18132145}
}
Kostenlos starten →